Global Prostate Cancer Diagnostics Market Study By Segment (Tumor Biomarker Tests, Imaging, Biopsy), By Market (< 55, 55-75Imaging, > 75), By Company (Genomic Health, Abbott, OPKO) 2015-2025
Report ID: 2247 | Sep 2018 | No. of Pages: 70
|
Snapshot
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tumor Biomarker Tests
Imaging
Biopsy
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
< 55
55-75
> 75
Company Coverage (Sales data, Main Products & Services etc.):
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tumor Biomarker Tests
Imaging
Biopsy
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
< 55
55-75
> 75
Company Coverage (Sales data, Main Products & Services etc.):
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Prostate Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Prostate Cancer Diagnostics Market by Type
2.1 By Type
2.1.1 Tumor Biomarker Tests
2.1.2 Imaging
2.1.3 Biopsy
2.1.4 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 < 55
3.1.2 55-75
3.1.3 > 75
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Genomic Health (Company Profile, Sales Data etc.)
5.2 Abbott (Company Profile, Sales Data etc.)
5.3 OPKO (Company Profile, Sales Data etc.)
5.4 Siemens Healthcare (Company Profile, Sales Data etc.)
5.5 DiaSorin (Company Profile, Sales Data etc.)
5.6 bioMeriux (Company Profile, Sales Data etc.)
5.7 Roche (Company Profile, Sales Data etc.)
5.8 MDx Health (Company Profile, Sales Data etc.)
5.9 Beckman Coulter (Company Profile, Sales Data etc.)
5.10 Myriad Genetics (Company Profile, Sales Data etc.)
5.11 Ambry Genetics (Company Profile, Sales Data etc.)
6 ConclusionTable Global Prostate Cancer Diagnostics Market 2015-2018, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market 2015-2018, by Type, in Volume
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2025, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2025, by Type, in Volume
Table Genomic Health Overview List
Table Prostate Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Prostate Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OPKO Overview List
Table Prostate Cancer Diagnostics Business Operation of OPKO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Siemens Healthcare Overview List
Table Prostate Cancer Diagnostics Business Operation of Siemens Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DiaSorin Overview List
Table Prostate Cancer Diagnostics Business Operation of DiaSorin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table bioMeriux Overview List
Table Prostate Cancer Diagnostics Business Operation of bioMeriux (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Prostate Cancer Diagnostics Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MDx Health Overview List
Table Prostate Cancer Diagnostics Business Operation of MDx Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beckman Coulter Overview List
Table Prostate Cancer Diagnostics Business Operation of Beckman Coulter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ambry Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Ambry Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Global Prostate Cancer Diagnostics Market Growth 2015-2018, by Type, in USD Million
Figure Global Prostate Cancer Diagnostics Market Growth 2015-2018, by Type, in Volume
1 Industry Overview
1.1 Prostate Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Prostate Cancer Diagnostics Market by Type
2.1 By Type
2.1.1 Tumor Biomarker Tests
2.1.2 Imaging
2.1.3 Biopsy
2.1.4 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 < 55
3.1.2 55-75
3.1.3 > 75
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Genomic Health (Company Profile, Sales Data etc.)
5.2 Abbott (Company Profile, Sales Data etc.)
5.3 OPKO (Company Profile, Sales Data etc.)
5.4 Siemens Healthcare (Company Profile, Sales Data etc.)
5.5 DiaSorin (Company Profile, Sales Data etc.)
5.6 bioMeriux (Company Profile, Sales Data etc.)
5.7 Roche (Company Profile, Sales Data etc.)
5.8 MDx Health (Company Profile, Sales Data etc.)
5.9 Beckman Coulter (Company Profile, Sales Data etc.)
5.10 Myriad Genetics (Company Profile, Sales Data etc.)
5.11 Ambry Genetics (Company Profile, Sales Data etc.)
6 ConclusionTable Global Prostate Cancer Diagnostics Market 2015-2018, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market 2015-2018, by Type, in Volume
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2025, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market Forecast 2019-2025, by Type, in Volume
Table Genomic Health Overview List
Table Prostate Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Prostate Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OPKO Overview List
Table Prostate Cancer Diagnostics Business Operation of OPKO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Siemens Healthcare Overview List
Table Prostate Cancer Diagnostics Business Operation of Siemens Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DiaSorin Overview List
Table Prostate Cancer Diagnostics Business Operation of DiaSorin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table bioMeriux Overview List
Table Prostate Cancer Diagnostics Business Operation of bioMeriux (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Prostate Cancer Diagnostics Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MDx Health Overview List
Table Prostate Cancer Diagnostics Business Operation of MDx Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beckman Coulter Overview List
Table Prostate Cancer Diagnostics Business Operation of Beckman Coulter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ambry Genetics Overview List
Table Prostate Cancer Diagnostics Business Operation of Ambry Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Global Prostate Cancer Diagnostics Market Growth 2015-2018, by Type, in USD Million
Figure Global Prostate Cancer Diagnostics Market Growth 2015-2018, by Type, in Volume
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments
Connect With Us
+1-707-633-0404
sales@search4research.com